GGrantIndex
Sort

64,565 grants matching drug discovery

Signal Transduction Events and the Regulation of Cell Growth

$864,019
Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2014 · CA

NIDA Epidemiology Training Program

$863,890
Renee M. Johnson · Johns Hopkins University · T32 · FY2016 · DA

Genes contributing for nicotine dependence in humans

$863,787
Kari Stefansson · Decode Genetics, Ehf · R01 · FY2011 · DA

Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)

$863,786
Amber Dahlin · Brigham And Women'S Hospital · R01 · FY2024 · HL

Development of the UValidate platform for the profiling of topically applied chemical agents.

$863,724
Peter Sykora · Amelia Technologies, Llc · R42 · FY2023 · ES

Epigenetic HIV Silencing in Macrophages

$863,603
Ronald G Collman · University Of Pennsylvania · R61 · FY2018 · AI

Unlocking the Chemical Space of Cancer-Associated Perturbations

$863,577
Donita C Brady · University Of Pennsylvania · R01 · FY2025 · CA

RNA: New Antimicrobial Strategies

$863,503
Adrian Ferrã‰-D'amar㉠· National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Epigenetic HIV Silencing in Macrophages

$863,500
Ronald G Collman · University Of Pennsylvania · R33 · FY2021 · AI

PROSTATE CANCER BIOMARKER DISCOVERY AND DRUG REPURPOSING USING CROSS-CANCER LEARNING.

$863,222
Wayne State University · · FY2021 · Defense Health Agency

Chronic HIV infection and Aging in NeuroAIDS (CHAIN) Center

$863,074
Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2016 · MH

Dynamics, Structure, and Function of Proteins by NMR and Computation

$862,963
Rafael P Bruschweiler · Ohio State University, The · · FY2017 · BIO

Validating targets in p. aeruginosa type III secretion using chemical probes

$862,926
Donald T Moir · Microbiotix, Inc · R01 · FY2012 · AI

Genetic Determinants of Epilepsy in Murine Systems

$862,733
Wayne N. Frankel · Columbia University Health Sciences · R37 · FY2019 · NS

Novel Adjuvant Discovery in Vaccine Therapy

$862,703
Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI

Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency

$862,674
Tomi K Sawyer · Courage Therapeutics, Inc. · R42 · FY2023 · DK

Open Drug Discovery Center for Alzheimer's Disease

$862,604
Allan I Levey · Emory University · U54 · FY2023 · AG

Systematic Investigation of Protein Ubiquitination in ARDS

$862,581
Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · HL

Safe-OPTION: Optical Physiology To Interrogate Oligonucleotide Neurotoxicity

$862,420
Fabricio Simao · Quiver Bioscience Inc. · R44 · FY2025 · NS

Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes

$862,395
Michael Darin Cameron · Scripps Research Institute, The · U01 · FY2012 · AA

Epigenetic HIV Silencing in Macrophages

$862,319
Ronald G Collman · University Of Pennsylvania · R33 · FY2020 · AI

Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression

$861,938
Patrick Sung · University Of Texas Hlth Science Center · R35 · FY2023 · CA

Small molecule enhancers of tumor immunity targeting the LPA5 GPCR

$861,845
Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA

Inhibitors of poxvirus enzymes as novel drugs

$861,830
Esteban Edward Mena · Lifepharms, Inc. · U01 · FY2007 · AI

Methamphetamine and Other Substance Use Disorder Genetics in Thailand

$861,802
Joel Gelernter · Yale University · R01 · FY2023 · DA